Cargando…
Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184290/ http://dx.doi.org/10.1186/1546-0096-12-S1-P66 |
| _version_ | 1782337820103278592 |
|---|---|
| author | Quartier, P Grom, A Ruperto, N Brunner, HI Schikler, K Erguven, M Goffin, L Hofer, M Kallinich, T Marzan, K Gaillez, C Lheritier, K Abrams, K Martini, A Lovell, DJ |
| author_facet | Quartier, P Grom, A Ruperto, N Brunner, HI Schikler, K Erguven, M Goffin, L Hofer, M Kallinich, T Marzan, K Gaillez, C Lheritier, K Abrams, K Martini, A Lovell, DJ |
| author_sort | Quartier, P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4184290 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41842902014-10-30 Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis Quartier, P Grom, A Ruperto, N Brunner, HI Schikler, K Erguven, M Goffin, L Hofer, M Kallinich, T Marzan, K Gaillez, C Lheritier, K Abrams, K Martini, A Lovell, DJ Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4184290/ http://dx.doi.org/10.1186/1546-0096-12-S1-P66 Text en Copyright © 2014 Quartier et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Quartier, P Grom, A Ruperto, N Brunner, HI Schikler, K Erguven, M Goffin, L Hofer, M Kallinich, T Marzan, K Gaillez, C Lheritier, K Abrams, K Martini, A Lovell, DJ Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis |
| title | Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis |
| title_full | Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis |
| title_fullStr | Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis |
| title_full_unstemmed | Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis |
| title_short | Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis |
| title_sort | efficacy of canakinumab in biologic-naïve versus previously biologic-exposed sjia patients: a 12 week pooled post-hoc analysis |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184290/ http://dx.doi.org/10.1186/1546-0096-12-S1-P66 |
| work_keys_str_mv | AT quartierp efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT groma efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT ruperton efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT brunnerhi efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT schiklerk efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT erguvenm efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT goffinl efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT hoferm efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT kallinicht efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT marzank efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT gaillezc efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT lheritierk efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT abramsk efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT martinia efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis AT lovelldj efficacyofcanakinumabinbiologicnaiveversuspreviouslybiologicexposedsjiapatientsa12weekpooledposthocanalysis |